Fangusaro, J., Onar-Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N., … Fouladi, M. (2017). LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. In Neuro-Oncology (Vol. 19, pp. iv34–iv35). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/nox083.141

Fangusaro, Jason, Arzu Onar-Thomas, Tina Y. Poussaint, Shengjie Wu, Azra H. Ligon, Neal Lindeman, Anu Banerjee, et al. “LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY.” In Neuro-Oncology, 19:iv34–35. Oxford University Press (OUP), 2017. https://doi.org/10.1093/neuonc/nox083.141.

Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, et al. LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. In: Neuro-Oncology. Oxford University Press (OUP); 2017. p. iv34–5.

Fangusaro, Jason, et al. “LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY.” Neuro-Oncology, vol. 19, no. suppl_4, Oxford University Press (OUP), 2017, pp. iv34–35. Crossref, doi:10.1093/neuonc/nox083.141.

Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Pollack IF, Jakacki RI, Qaddoumi I, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Pfister SM, Jones DTW, Vezina G, Stern J, Panigrahy A, Jones BV, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Doyle LA, Smith M, Boyett JM, Dunkel IJ, Fouladi M. LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY. Neuro-Oncology. Oxford University Press (OUP); 2017. p. iv34–iv35.